dihydroergotamine has been researched along with Arterial Occlusive Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (90.91) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gasic, S; Probst, P | 1 |
| Hoffmann, J | 1 |
| Wampola, H | 1 |
| Preuss, EG | 1 |
| Brüning, G | 1 |
| Schuster, CJ; von Ungern-Sternberg, AF | 1 |
| Schulte, B | 1 |
| Hommes, OR | 1 |
| Kreuzer, H; Menzel, F; Schmidt, G; Vetterlein, F | 1 |
| Heidrich, H | 1 |
| Kulling, KG; Lund, F; Magaard, F; Magnusson, I; Stånge, K; Törngren, S | 1 |
3 trial(s) available for dihydroergotamine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
[Conservative treatment of peripheral arterial occlusive diseases].
Topics: Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Drug Evaluation; Female; Humans; Male; Middle Aged; Vasodilator Agents; Yohimbine | 1978 |
[Clinical treatment of peripheral arterial occlusive diseases].
Topics: Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Drug Evaluation; Ergoloid Mesylates; Ergotamines; Female; Hemodynamics; Humans; Male; Middle Aged; Yohimbine | 1976 |
[Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
Topics: Arterial Occlusive Diseases; Cardiovascular Agents; Cinnarizine; Clinical Trials as Topic; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Exercise Test; Flunarizine; Humans; Intermittent Claudication; Nafronyl; Pentoxifylline; Placebos; Pyrrolidines; Secologanin Tryptamine Alkaloids; Yohimbine | 1985 |
8 other study(ies) available for dihydroergotamine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
[Prinzmetal angina].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angina Pectoris; Animals; Arterial Occlusive Diseases; Atropine; Blood Pressure; Cardiac Catheterization; Catecholamines; Coronary Artery Bypass; Coronary Vessels; Dihydroergotamine; Dogs; Heart Rate; Humans; Muscle Tonus; Myocardial Infarction; Nitroglycerin; Nylidrin; Physical Exertion; Rest | 1975 |
[Therapy of chronic arterial occlusive disease. Studies with an orally administered drug under ambulatory conditions].
Topics: Adult; Aged; Arterial Occlusive Diseases; Diabetes Complications; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Drug Evaluation; Ergotamines; Female; Gangrene; Humans; Intermittent Claudication; Leg Ulcer; Male; Middle Aged; Pulse; Yohimbine | 1977 |
[Functional peripheral ischemia].
Topics: Arterial Occlusive Diseases; Aspirin; Cyanosis; Dihydroergotamine; Erythromelalgia; Hot Temperature; Humans; Neurocirculatory Asthenia; Psychotherapy; Raynaud Disease | 1979 |
[Observations during ambulatory therapy of functional and organic circulatory disorders with Defluina].
Topics: Adult; Arterial Occlusive Diseases; Cerebrovascular Disorders; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Ergoloid Mesylates; Ergotamines; Extremities; Humans; Male; Middle Aged; Secologanin Tryptamine Alkaloids | 1975 |
[Parameters for the measurement of long-term effects of an orally administered drug in organic and functional circulatory disorders. Preliminary communication].
Topics: Adult; Arterial Occlusive Diseases; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Drug Evaluation; Female; Humans; Male; Raynaud Disease; Secologanin Tryptamine Alkaloids; Vasodilator Agents | 1976 |
[Vertebrobasilary insufficiency].
Topics: Aged; Arterial Occlusive Diseases; Basilar Artery; Diabetes Complications; Dihydroergotamine; Female; Headache; Humans; Hypertension; Male; Middle Aged; Unconsciousness; Vertebral Artery; Vertigo; Vision Disorders | 1977 |
Acute changes in microvascular blood flow distribution in the myocardium of the rat during partial occlusion of the right coronary artery; effects of dihydroergotamine.
Topics: Animals; Arterial Occlusive Diseases; Coronary Circulation; Coronary Disease; Dihydroergotamine; Male; Microcirculation; Perfusion; Rats; Rats, Inbred Strains; Time Factors | 1991 |
[Severe arterial spasm in a patient after treatment with dihydroergotamine heparin].
Topics: Angiography; Arm; Arterial Occlusive Diseases; Dihydroergotamine; Drug Combinations; Heparin; Humans; Male; Middle Aged | 1986 |